
COVID-19 Hits Dividends as Businesses Take Stock
March 20, 2020
Read More
ESG key in Covid-19 fightback, warns ECODA
April 2, 2020
Read More
ECB: COVID-19 The Capital and Pay Response
April 3, 2020
Read More
FCA pledges to protect shareholders as fundraising requirements are eased
April 13, 2020
Read More
COVID-19 brings social investment to the fore
April 30, 2020
Read More
UK-listed companies offered Covid-19 issuance lifeline
September 11, 2020
Read More
UK govt extends AGM leeway to end of 2020
October 2, 2020
Read More
Investor Forum embraces ‘stakeholder capitalism’
January 21, 2021
Read More
Regulators warn Covid-19 could delay UK company reporting
January 29, 2021
Read More
What about the “S” in ESG? - COVID-19 raises need for greater transparency
May 21, 2021
Transparency in reporting on social issues is a powerful way for businesses to build trust, create accountability, show leadership, and move the dial on seemingly indelible industry-wide issues. It is also a key factor for ESG investors who want to show alignment with increasingly stringent ESG regulations.
Read More
Covid-19 triggers fall in Japanese sustainable assets
July 19, 2021
The use of ESG integration strategies have increased by 15.4% year on year in Japan, despite a decrease in the country’s sustainable investment balance, a Japan Sustainable Investment Forum (SIF) White Paper has found.
Read More
Australia confronts Jobkeeper profiteering amidst disclosure concerns
July 23, 2021
With Australian proxy season preparations now underway, the Australian federal authorities are looking to introduce a public register of companies that use the government’s JobKeeper programme. Debates around the proposed bill centre over the impact and fairness of Covid furlough support and a lack of corporate transparency over the uptake and use of wage subsidies.
Read More
Pfizer issues $1bn sustainability bond
August 27, 2021
Pfizer has increased its presence in the growing sustainable debt market by issuing a $1 billion sustainability bond which will support the delivery of the Covid-19 vaccine.
Read More
Moderna faces shareholder backlash on remuneration
May 5, 2023
Read More